SCHEMBL21147382

SCHEMBL21147382

c1ccc(-c2cccc(-c3nc(-c4ccc(-c5ccccc5)c(-n5c6ccccc6c6ccccc65)c4)nc(-c4ccc(-c5ccccc5)c(-n5c6ccccc6c6ccccc65)c4)n3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
ATM Q13315 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 3/20 0.36
GP6 Q9HCN6 1/20 0.36
PDE7A Q13946 2/20 0.35
PDE7B Q9NP56 2/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33
ASH1L Q9NR48 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21147592 0.99 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1GP6
SCHEMBL21147351 0.97 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1GP6
SCHEMBL21147354 0.97 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1GP6
SCHEMBL21146998 0.97 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1GP6
SCHEMBL21147350 0.97 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1GP6
SCHEMBL21147000 0.97 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1GP6
SCHEMBL21147347 0.97 KDM4E (0.40) KDM4EATML3MBTL1ALDH1A1MEN1
SCHEMBL21147409 0.96 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1GP6
SCHEMBL21147324 0.96 ATM (0.41) KDM4EATML3MBTL1ALDH1A1MEN1
SCHEMBL21147330 0.96 ATM (0.41) KDM4EATML3MBTL1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-20200212314-A1 ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 US disclosed
US-20190214570-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CRY1, CYP1B1, CYP1A1 KDM4E 2739/4885ATM 2932/4885L3MBTL1 1990/4885
US-20190214570-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND CRY1, CYP1B1, CYP1A1 KDM4E 2739/4885ATM 2932/4885L3MBTL1 1990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.